KPV
A synthetic tripeptide (Lysine-Proline-Valine) derived from the C-terminus of alpha-MSH, studied in preclinical inflammation research.
Customers also frequently order with
What research has studied about KPV
KPV is a short synthetic tripeptide composed of the amino acids lysine, proline, and valine (Lys-Pro-Val), corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). Research studies it as a fragment that retains anti-inflammatory signalling properties associated with the parent peptide without its pigmentary activity.
Laboratory research on KPV has examined its effects on inflammatory signalling pathways and cytokine production in cell and animal models. These are preclinical observations reported in the literature; nothing here describes use in humans.
Certificate of Analysis
Every KPV lot is tested by an independent third-party lab and ships with its lot-matched Certificate of Analysis. This lot’s certificate is available on request — contact us and we will send it over.
Specifications
| Compound | KPV |
| Available sizes | 10 mg |
| Form | Lyophilized powder |
| Purity | Measured by HPLC; see the Certificate of Analysis for the lot |
| Storage | Store cold and away from light per your lab protocol |
| Intended use | Laboratory and research use only |
Research context
For the published literature, search PubMed for “KPV peptide alpha-MSH”. Steadfast supplies this material for laboratory research use only.
Frequently asked questions
What is KPV?
KPV is a synthetic Lys-Pro-Val tripeptide derived from alpha-MSH, studied in preclinical inflammation research. Steadfast supplies it as a lyophilized research material for laboratory use only.
What has research studied about KPV?
Research has examined its effects on inflammatory signalling and cytokine production in laboratory and animal models.
Is it intended for human use?
No. It is a research chemical for in-vitro laboratory research only, not a drug or supplement.